The EPO has opened its public user consultation on the latest version of the EPC and PCT-EPO Guidelines, which will come into force on 1 March 2023. Users are invited to submit their comments in any…
The new and noteworthy decision T 670/20 by Technical Board of Appeal 3.3.07 provides more legal certainty for patentees of formulation patents.
The proprietors of pharmaceutical formulation and…
Damocles, so tells us an ancient legend (reported here) was a favorite of President Dionysios II. of Syrakus in Sicily, who lived during the first half of the 4th century BC. His story was succinctly…
An outburst of anger of a president and his re-election, social tensions, industrial actions: for anyone familiar with the world of patents it will be clear that all this refers to the European…
Video conferences will become the default format of oral opposition proceedings in at the European Patent Office as of 2023. Only under certain circumstances, and when the opposition division permits…
As per the EPC definition, a substance or composition that is already known to have been used in a “first medical use” may still be patentable for any second or further use, provided that said use is…
The member states of the European Patent Organisation have re-appointed EPO president António Campinos for a second five-year term in office, commencing 1 July 2023.
The decision was made at a…
Staff members of the European Patent Office will demonstrate in front of the Isar building in Munich during the meeting of the Administrative Council on 29 June 2022, where re-election of president…
The trade union SUEPO has claimed the strike it called for during the meeting of the Administrative Council on 22 March 2022 was a ‘striking success’.
According to a statement it sent to its members…
